Home/Filings/4/0001415889-24-003965
4//SEC Filing

Buck Elizabeth 4

Accession 0001415889-24-003965

CIK 0001701541other

Filed

Feb 14, 7:00 PM ET

Accepted

Feb 15, 5:36 PM ET

Size

5.6 KB

Accession

0001415889-24-003965

Insider Transaction Report

Form 4
Period: 2024-02-14
Buck Elizabeth
CHIEF SCIENTIFIC OFFICER
Transactions
  • Award

    Stock Option (Right to Buy)

    2024-02-14+200,000200,000 total
    Exercise: $4.86Exp: 2034-02-13Common Stock (200,000 underlying)
Footnotes (1)
  • [F1]25% of the shares subject to this option shall vest and become exercisable on February 14, 2025, with the remainder vesting in 36 equal monthly installments thereafter.

Issuer

Black Diamond Therapeutics, Inc.

CIK 0001701541

Entity typeother

Related Parties

1
  • filerCIK 0001880385

Filing Metadata

Form type
4
Filed
Feb 14, 7:00 PM ET
Accepted
Feb 15, 5:36 PM ET
Size
5.6 KB